MedPath

Significance of Synbiotics on Inflammation and Proliferation of Colonic Mucosa

Not Applicable
Completed
Conditions
Inflammation
Interventions
Dietary Supplement: Lactobacillus
Dietary Supplement: Bifidobacterium
Registration Number
NCT01534572
Lead Sponsor
Region Skane
Brief Summary

There is a constant exchange between the gut epithelium and lumen, including microbial interplay. The aim of this study was to investigate dietary test products on inflammatory proliferation markers in the gut, and thereby if the products had positive effects in the gut as well as in other parts of the body.

The hypothesis was that the test products would reduce the inflammatory and proliferation activity of the gut epithelium by fermentation of normal food products and by converting dietary phenolic compounds into anti-inflammatory substances.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
12
Inclusion Criteria
  • 18-80 years old,
  • Able to understand oral and written information,
  • Informed consent
Exclusion Criteria
  • Ongoing immune suppressive treatment, incl. cortisone,
  • Ongoing antibiotic treatment or antibiotic treatment ended within 4 weeks,
  • History of inflammatory bowel disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Probiotics_LactobacillusLactobacillusIntervention (2 weeks) with a strain of Lactobacillus
Probiotics_BifidobacteriumBifidobacteriumIntervention (2 weeks) of daily supplementation of a probiotic strain of Bifidobacterium.
Primary Outcome Measures
NameTimeMethod
Reactivity of rectal mucosaafter 2 weeks intervention

to study the reactivity of rectal mucosa after a standardized inflammatory insult before and after treatment with probiotics

Secondary Outcome Measures
NameTimeMethod
influence on immune systemafter 2 weeks intervention

to study the influence on systemic leukocytes and regulatory T cells

© Copyright 2025. All Rights Reserved by MedPath